Candriam increased its Kyndryl stake amid earnings miss, guidance cut, and regulatory scrutiny, sparking stock volatility.

Candriam S.C.A. boosted its stake in Kyndryl Holdings (KD) by 313.5% in Q3 2026, holding $17.2 million in shares. Kyndryl reported Q3 earnings of $0.52 per share, missing estimates by $0.08, and revenue of $3.86 billion, slightly below expectations. The company lowered its full-year 2026 revenue guidance, contributing to a negative market reaction. The stock, trading at $10.57, faces volatility due to leadership changes, a delayed filing, and a BFA regulatory investigation. Analysts have downgraded the stock, with a consensus "Hold" rating and a target price of $32.80.